Overall rank by patents
#6,764
of 50,000 tracked assignees
USPTO PatentsView assignee record - 49 granted patents across 28 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
According to USPTO PatentsView, Endress+hauser ranks #6,764 of 50,000 tracked US assignees by granted-patent volume, with 49 patents across 28 technology areas.
USPTO PatentsView assignee plate
Corpus R6764 · Foreign Corporation #6,764 · 49 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Editas Medicine, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Endress+hauser Condu… · this assignee
40 score
Genband US · near
40 score
Tellabs Operations · near
40 score
The USA As Represent… · near
40 score
Beijing BOE Multimed… · near
40 score
3D Lighting Innovati… · lowest
7 score
What this shows Endress+hauser Conducta Gesellschaft Fuer Mess- Und Regeltechnik Mbh + Co. KG stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-DROP, BOOK-FULL. Volume places it #6,764 of 50,000; Innovation Score 40.4/100 sits in the top 36% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Editas Medicine, Inc. (±0 grants).
Endress+hauser Conducta Gesellschaft Fuer Mess- Und Regeltechnik Mbh + Co. KG has been granted 49 US utility patents between 2015 and 2021, placing Endress+hauser Conducta Gesellschaft Fuer Mess- Und Regeltechnik Mbh + Co. KG at #6,764 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 28 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.6 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Endress+hauser Conducta Gesellschaft Fuer Mess- Und Regeltechnik Mbh + Co. KG is one of the more focused assignees in the PatentsView dataset. By volume, Endress+hauser sits between Evatec Ag (49 patents, rank #6,764) and Friedrich-schiller-universitat Jena (49 patents, rank #6,772) - the closest US assignees by grant volume. The composite Innovation Score of 40.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 1 grants, compared with 48 in the 2015–2019 window, a -98% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Endress+hauser Conducta Gesellschaft Fuer Mess- Und Regeltechnik Mbh + Co. KG's 13.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 28 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EVATEC AG
49 patents
EXMARK MANUFACTURING COMPANY INCORPORATED
49 patents
Editas Medicine, Inc.
49 patents
Elite Semiconductor Microelectronics Technology Inc.
49 patents
Express Imaging Systems, LLC
49 patents
FIDIA FARMACEUTICI S.p.A.
49 patents
Fairfield Industries Incorporated
49 patents
Friedrich-Schiller-Universitat Jena
49 patents
Endress+Hauser Conducta Gesellschaft fuer Mess- und Regeltechnik mbH + Co. KG
49 patents
What this shows Endress+hauser holds 49 patents at rank #6,768, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,768 in granted patent volume.
Other assignees with the most granted patents in Endress+hauser's primary technology class.
Two PlainPatent-derived peer sets for Endress+hauser, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (40 here).
Endress+hauser's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 36 | 73.5% |
| 2016 | 11 | 22.4% |
| 2017 | 1 | 2.0% |
| 2021 | 1 | 2.0% |
Top 15 of 28 technology areas
Overall rank by patents
#6,764
of 50,000 tracked assignees
40.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.